These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33586568)

  • 21. Interspecies uncertainty in molecular responses and toxicity of mixtures.
    Mumtaz MM; Pohl HR
    Exp Suppl; 2012; 101():361-79. PubMed ID: 22945575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human variability in hepatic and renal elimination: implications for risk assessment.
    Dorne JL
    J Appl Toxicol; 2007; 27(5):411-20. PubMed ID: 17497760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human iPSC-derived neuronal models for in vitro neurotoxicity assessment.
    Tukker AM; Wijnolts FMJ; de Groot A; Westerink RHS
    Neurotoxicology; 2018 Jul; 67():215-225. PubMed ID: 29909083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches.
    Paparella M; Bennekou SH; Bal-Price A
    Reprod Toxicol; 2020 Sep; 96():327-336. PubMed ID: 32781019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Challenge for Adverse Outcome Pathway (AOP)-based Chemical Safety Assessment].
    Yamada T; Ashikaga T; Kojima H; Hirose A
    Yakugaku Zasshi; 2020; 140(4):481-484. PubMed ID: 32238628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk.
    Kumar KK; Aboud AA; Bowman AB
    Neurotoxicology; 2012 Jun; 33(3):518-29. PubMed ID: 22330734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining in vitro assays and mathematical modelling to study developmental neurotoxicity induced by chemical mixtures.
    Pistollato F; Carpi D; Mendoza-de Gyves E; Paini A; Bopp SK; Worth A; Bal-Price A
    Reprod Toxicol; 2021 Oct; 105():101-119. PubMed ID: 34455033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and analysis of an adverse outcome pathway network for human neurotoxicity.
    Spinu N; Bal-Price A; Cronin MTD; Enoch SJ; Madden JC; Worth AP
    Arch Toxicol; 2019 Oct; 93(10):2759-2772. PubMed ID: 31444508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of peripheral neurotoxicity associated with four chemotherapy drugs using human induced pluripotent stem cell-derived peripheral neurons.
    Wang M; Wang J; Tsui AYP; Li Z; Zhang Y; Zhao Q; Xing H; Wang X
    Toxicol In Vitro; 2021 Dec; 77():105233. PubMed ID: 34390763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards animal-free neurotoxicity screening: Applicability of hiPSC-derived neuronal models for in vitro seizure liability assessment.
    Tukker AM; Van Kleef RGDM; Wijnolts FMJ; De Groot A; Westerink RHS
    ALTEX; 2020; 37(1):121-135. PubMed ID: 31686111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrative translational framework for chemical induced neurotoxicity - a systematic review.
    Deepika D; Sharma RP; Schuhmacher M; Kumar V
    Crit Rev Toxicol; 2020 May; 50(5):424-438. PubMed ID: 32530349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic data reduce uncertainty in the acceptable daily intake for benzoic acid and its salts.
    Zu K; Pizzurro DM; Lewandowski TA; Goodman JE
    Regul Toxicol Pharmacol; 2017 Oct; 89():83-94. PubMed ID: 28720346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approach to Neurotoxicity using Human iPSC Neurons: Consortium for Safety Assessment using Human iPS Cells.
    Shirakawa T; Suzuki I
    Curr Pharm Biotechnol; 2020; 21(9):780-786. PubMed ID: 31782362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
    Chou WC; Lin Z
    Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the time right for in vitro neurotoxicity testing using human iPSC-derived neurons?
    Tukker AM; de Groot MW; Wijnolts FM; Kasteel EE; Hondebrink L; Westerink RH
    ALTEX; 2016; 33(3):261-71. PubMed ID: 27010910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
    Bokkers BG; Slob W
    Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
    Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B
    Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block.
    Paci M; Hyttinen J; Rodriguez B; Severi S
    Br J Pharmacol; 2015 Nov; 172(21):5147-60. PubMed ID: 26276951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.